ES2093194T3 - Inmunoensayo para detectar streptococcus del grupo b. - Google Patents

Inmunoensayo para detectar streptococcus del grupo b.

Info

Publication number
ES2093194T3
ES2093194T3 ES92303523T ES92303523T ES2093194T3 ES 2093194 T3 ES2093194 T3 ES 2093194T3 ES 92303523 T ES92303523 T ES 92303523T ES 92303523 T ES92303523 T ES 92303523T ES 2093194 T3 ES2093194 T3 ES 2093194T3
Authority
ES
Spain
Prior art keywords
rhap
group
immuno assay
estio
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92303523T
Other languages
English (en)
Inventor
Harold Jennings
Francis Michon
Martial Lacroix
Robert Chalifour
Robert Feldman
Dennis Kasper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Council of Canada
Harvard College
Brigham and Womens Hospital Inc
Original Assignee
National Research Council of Canada
Harvard College
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Council of Canada, Harvard College, Brigham and Womens Hospital Inc filed Critical National Research Council of Canada
Application granted granted Critical
Publication of ES2093194T3 publication Critical patent/ES2093194T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

COMBINACIONES INMUNOABSORBENTES PARA LA DETECCION Y DIAGNOSTICO DE UN ANTIGENO POLISACARIDO DE UN ESTREPTOCOCO DEL GRUPO B, QUE CONTIENEN UN PORTADOR INDISOLUBLE, UN AGENTE DE CAPTURA QUE TIENE UNA AFINIDAD A ENLAZARSE ESPECIFICAMENTE AL EPITOPE DE TRIRAMNOSA DEL ANTIGENO DEL ESTREPTOCOCO DEL GRUPO B Y QUE TIENEN LA FORMULA O-L-RHAP(1->2)-O-L-RHAP(1->2)O-RHAP-1EN DONDE RHAP ES RAMNOSA Y UN AGENTE MARCADOR DE ANTIGENOS QUE TIENE UNA AFINIDAD A ENLAZARSE A UN EPITOPE DE MONORAMNOSA DEL ANTIGENO POLISACARIDO DE UN ESTREPTOCOCO DEL GRUPO B DE LA FORMULA O-L-RHAP-1 ESTA ENLAZADO AL PORTADOR. TAMBIEN SE DESCRIBEN UN KIT DE PRUEBA PARA EL METODO DEL INMUNOENSAYO Y UN ANTICUERPO POLICLONAL.
ES92303523T 1991-04-25 1992-04-21 Inmunoensayo para detectar streptococcus del grupo b. Expired - Lifetime ES2093194T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/691,310 US5225331A (en) 1991-04-25 1991-04-25 Immunoassay for detecting group b streptococcus

Publications (1)

Publication Number Publication Date
ES2093194T3 true ES2093194T3 (es) 1996-12-16

Family

ID=24776026

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92303523T Expired - Lifetime ES2093194T3 (es) 1991-04-25 1992-04-21 Inmunoensayo para detectar streptococcus del grupo b.

Country Status (15)

Country Link
US (1) US5225331A (es)
EP (1) EP0510902B1 (es)
JP (1) JP3270043B2 (es)
AP (1) AP331A (es)
AT (1) ATE139846T1 (es)
AU (1) AU664366B2 (es)
CA (1) CA2109090A1 (es)
DE (1) DE69211762D1 (es)
DK (1) DK0510902T3 (es)
ES (1) ES2093194T3 (es)
IE (2) IE921232A1 (es)
IL (1) IL101656A (es)
NZ (1) NZ242433A (es)
WO (1) WO1992019969A1 (es)
ZA (1) ZA922975B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030044777A1 (en) * 1993-10-28 2003-03-06 Kenneth L. Beattie Flowthrough devices for multiple discrete binding reactions
EP0699906B1 (de) 1994-07-25 2002-04-24 Roche Diagnostics GmbH Verfahren zum Nachweis der Kontamination einer Oberfläche mit einem Analyten
US5811403A (en) * 1996-09-30 1998-09-22 Vanderbilt University Polysaccharide toxin from Group B β-hemolytic Streptococcus (GBS) having improved purity
US5858991A (en) * 1997-01-29 1999-01-12 Vanderbilt University Facilitation of wound healing with CM101/GBS toxin
US6028060A (en) * 1997-01-29 2000-02-22 Vanderbilt University Treatment of chronic inflammatory diseases with CM101/GBS toxin
US6670337B1 (en) 1998-01-29 2003-12-30 Yeda Reaearch And Development Co., Ltd. Facilitation of wound healing with CM101/GBS toxin
US5981508A (en) 1997-01-29 1999-11-09 Vanderbilt University Facilitation of repair of neural injury with CM101/GBS toxin
US6756361B1 (en) * 1997-10-14 2004-06-29 Nabi Enterococcus antigens and vaccines
US6004754A (en) * 1998-01-21 1999-12-21 Becton Dickinson And Company DNA sequence, related probes and primers for the detection of Streptococcus agalactiae
CN1944652A (zh) * 1998-02-20 2007-04-11 益德生物医药公司 B组链球菌抗原
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
CA2364983A1 (en) * 2000-12-13 2002-06-13 John R. Coleman Nucleic acid molecules and polypeptides for catabolism of abscisic acid
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US6720160B2 (en) * 2001-10-11 2004-04-13 Helica Biosystems, Inc. Method for simultaneous detection of multiple microbial antigens in biological specimens from mastitic animals
CA2475821C (en) * 2002-02-11 2011-12-13 Shire Biochem Inc. Group b streptococcus antigens
CN1207005C (zh) * 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
BRPI1012675A2 (pt) 2009-06-26 2016-04-05 Soricimed Biopharma Inc compostos e métodos para a detecção de cânceres expressando trpv-6 e liberação de fármacos
CN111690711A (zh) * 2020-07-13 2020-09-22 北京海关技术中心 棉签中铜绿假单胞菌定性检测能力验证样品及其制备方法
CN115856319B (zh) * 2022-11-30 2023-07-28 中拓生物有限公司 一种可溶性生长刺激表达基因2蛋白测定试剂盒及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003987A1 (en) * 1985-12-17 1987-07-02 Southwest Research Institute Method and apparatus for detecting and locating leaks in geomembrane liners
US4970070A (en) * 1986-02-07 1990-11-13 Genetic Systems Corporation Protective monoclonal antibody compositions for infections due to group B streptococcus

Also Published As

Publication number Publication date
AP9200377A0 (en) 1992-04-30
IL101656A (en) 1997-01-10
AU1567592A (en) 1992-12-21
EP0510902B1 (en) 1996-06-26
DK0510902T3 (da) 1996-11-04
US5225331A (en) 1993-07-06
NZ242433A (en) 1993-05-26
AP331A (en) 1994-04-14
IE921344A1 (en) 1992-11-04
DE69211762D1 (de) 1996-08-01
IL101656A0 (en) 1992-12-30
EP0510902A1 (en) 1992-10-28
JPH06507014A (ja) 1994-08-04
CA2109090A1 (en) 1992-10-26
ZA922975B (en) 1993-06-18
IE921232A1 (en) 1992-11-04
JP3270043B2 (ja) 2002-04-02
WO1992019969A1 (en) 1992-11-12
ATE139846T1 (de) 1996-07-15
AU664366B2 (en) 1995-11-16

Similar Documents

Publication Publication Date Title
ES2093194T3 (es) Inmunoensayo para detectar streptococcus del grupo b.
Levine et al. Specificities of prostaglandins B1, F1α, and F2α antigen-antibody reactions
ES2103803T3 (es) Ensayo inmunocromatografico y metodo para utilizar el mismo.
ES2145924T3 (es) Procedimiento para detectar anticuerpos.
ES2093778T3 (es) Nuevos anticuerpos y metodos para su uso.
ES2070107T3 (es) Ensayo de antigeno especifico de la prostata (psa) libre y complejado.
FI970301A (fi) Spesifisen immunoglobuliinin määrittäminen käyttäen useampaa antigeenia
DK1232392T3 (da) Forbedret fremgangsmåde til påvisning af syreresistente bakterier af slægten Helicobacter i afføring
AR006016A1 (es) Metodo para determinar h.pylori en muestras fecales y un equipo (kit) para realizar dicho metodo
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
ES2082777T3 (es) Un metodo para la deteccion de un anti-cuerpo y antigeno en un inmunoensayo.
ES2162347T3 (es) Deteccion de igm especifica para un antigeno.
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
FR2746398B1 (fr) Anticorps specifique de staphylococcus aureaus, et utilisations
ATE93970T1 (de) Immunoenzymatischer elisatest auf einer einzelplatte mit kompetitiver inhibition zum nachweis von antisporozoit-antikoerpern von plasmodium falciparum.
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
EP0245052A3 (en) Detection of inflammation and novel antibodies therefor
KR930700548A (ko) 자궁내막 항체 측정방법 및 측정용 자궁내막 항원, 조성물, 테스트킷
SE8601695D0 (sv) Fast-fasanalysmetod
ATE190656T1 (de) Verfahren zur prüfung für salmonella
ES552074A0 (es) Un metodo en emparedado de doble anticuerpo para detectar o ensayar un antigeno seleccionado de urocinasa humana y un precursor de la misma
Andrieu et al. Viroimmunoassay of prostaglandin F2α at the picogram level
ES2066739B1 (es) Inmunoensayo para analitos en muestras empleando agentes alquilantes.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 510902

Country of ref document: ES